News Daily News FDA Approves Vericiguat for High-risk Patients With HF Michael O'Riordan January 20, 2021
News Daily News Unplanned PCI Rare After TAVI, but Operators Get Good Results Michael O'Riordan January 18, 2021
News Daily News CAC Screening Cost-effective for Statin Decisions in Hereditary CAD Michael O'Riordan January 14, 2021
News Daily News Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic Michael O'Riordan January 12, 2021
News Daily News One in Four US Physicians Report Personal Attacks on Social Media Michael O'Riordan January 05, 2021
News Daily News Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests Michael O'Riordan January 05, 2021
News Daily News ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show Michael O'Riordan December 21, 2020
News Daily News Knowing Comorbidities, Medication Use May Save Lives in COVID-19 Michael O'Riordan December 15, 2020
News Daily News Inclisiran Approved in Europe for Lowering LDL Cholesterol Michael O'Riordan December 11, 2020
News Daily News In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition Michael O'Riordan December 11, 2020
News Daily News Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD Michael O'Riordan December 07, 2020
News Daily News Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much Michael O'Riordan November 26, 2020
News Daily News CAC Testing Improves Pretest Probability of Obstructive CAD Michael O'Riordan November 23, 2020
News Daily News Lotus Edge TAVR Device Recalled and Discontinued Worldwide Michael O'Riordan November 18, 2020
News Daily News CMR Picks Up Pericardial Inflammation in Student Athletes With COVID-19 Michael O'Riordan November 06, 2020
News Daily News Payments to Docs Appear to Influence Implantable Device Selection Michael O'Riordan November 04, 2020
News Daily News Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5 Michael O'Riordan November 03, 2020
News Daily News CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices Michael O'Riordan October 30, 2020